Research Study: PREVENTABLE
Condition:
prevention
Study Sponsor: PCORNet
Study Investigator: Sandy Oberembt, PA
Study Contact: Stephanie Ebnet
Stephanie.ebnet@allina.com
612-863-6286
Every research study comes with its own unique risks and benefits; the study team will assess whether you’re an eligible candidate and ensure you’re provided with all the information you need to decide if participating is right for you.
About this Study:

PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.
Eligibility Criteria:

  • Community-dwelling adults
  • Age 75 years or older

Interested in participating in this study?

Reach out to the study contact directly, or fill out this form and we will contact you and assess whether you are an eligible candidate!